世界のデフェラシロクスAPI市場インサイト・予測（～2027年）

• 英文タイトル：Global Deferasirox API Market Insights and Forecast to 2027

• レポートコード：QY2108PAL1083 • 出版社/出版日：QYResearch / 2021年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、129ページ • 納品方法：Eメール（納期：3日） • 産業分類：化学＆材料

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査資料はデフェラシロクスAPIの世界市場の現状について調査・分析し、2027年までの市場を予測しました。デフェラシロクスAPIの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（純度≥98％、純度<98％）、用途別市場規模（デフェラシロクス錠、その他）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。 ・デフェラシロクスAPIの世界市場概要 ・メーカー別の競争状況、市場シェア ・デフェラシロクスAPIの種類別市場規模：純度≥98％、純度<98％ ・デフェラシロクスAPIの用途別市場規模：デフェラシロクス錠、その他 ・北米のデフェラシロクスAPI市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ） ・ヨーロッパのデフェラシロクスAPI市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス） ・アジアのデフェラシロクスAPI市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国） ・中南米のデフェラシロクスAPI市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル） ・中東・アフリカのデフェラシロクスAPI市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア） ・企業情報：Piramal Enterprises Limited、Alkaloids Corporation、Zhejiang Hengkang Pharmaceutical、Om Pharmaceutical Industries、Teva API、Symed Labs Limited、Neuland Laboratories、Parabolic Drugs Limited、YUNG ZIP CHEMICAL INDUSTRIAL、Erregierre SpA、Glenmark Pharmaceuticals、Cipla、Sun Pharmaceutical Industries Ltd.、Jubilant Pharma、CTX Lifesciences、Waterstone Pharmaceuticals Inc.、Bal Pharma Ltd.、Curequest Lifescience ・デフェラシロクスAPIのバリューチェーン・販売チャネル分析 ・デフェラシロクスAPIの世界市場動向

Deferasirox is a synthetic, orally bioavailable, achiral, tridentate triazole derived from salicylic acid with iron-chelating activity. Deferasirox chelates iron at a 2:1 (ligand:iron) ratio. Because of its oral availability and long plasma half-life, this agent may be superior to desferrioxamine (desferal, DFO), which is orally inactive and has a short plasma half-life.

Market Analysis and Insights: Global Deferasirox API Market
The global Deferasirox API market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.

Global Deferasirox API Scope and Segment
Deferasirox API market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Deferasirox API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Purity≥98%
Purity<98% Segment by Application Deferasirox Tablets Others By Company Piramal Enterprises Limited Alkaloids Corporation Zhejiang Hengkang Pharmaceutical Om Pharmaceutical Industries Teva API Symed Labs Limited Neuland Laboratories Parabolic Drugs Limited YUNG ZIP CHEMICAL INDUSTRIAL Erregierre SpA Glenmark Pharmaceuticals Cipla Sun Pharmaceutical Industries Ltd. Jubilant Pharma CTX Lifesciences Waterstone Pharmaceuticals Inc. Bal Pharma Ltd. Curequest Lifescience Production by Region Europe China China Taiwan India Consumption by Region North America United States Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia China Taiwan Indonesia Thailand Malaysia Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia UAE

レポート目次

---

1 Study Coverage
1.1 Deferasirox API Product Introduction
1.2 Market by Type
1.2.1 Global Deferasirox API Market Size Growth Rate by Type
1.2.2 Purity≥98%
1.2.3 Purity<98% 1.3 Market by Application 1.3.1 Global Deferasirox API Market Size Growth Rate by Application 1.3.2 Deferasirox Tablets 1.3.3 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Deferasirox API Production 2.1 Global Deferasirox API Production Capacity (2016-2027) 2.2 Global Deferasirox API Production by Region: 2016 VS 2021 VS 2027 2.3 Global Deferasirox API Production by Region 2.3.1 Global Deferasirox API Historic Production by Region (2016-2021) 2.3.2 Global Deferasirox API Forecasted Production by Region (2022-2027) 2.4 Europe 2.5 China 2.6 China Taiwan 2.7 India 3 Global Deferasirox API Sales in Volume & Value Estimates and Forecasts 3.1 Global Deferasirox API Sales Estimates and Forecasts 2016-2027 3.2 Global Deferasirox API Revenue Estimates and Forecasts 2016-2027 3.3 Global Deferasirox API Revenue by Region: 2016 VS 2021 VS 2027 3.4 Global Top Deferasirox API Regions by Sales 3.4.1 Global Top Deferasirox API Regions by Sales (2016-2021) 3.4.2 Global Top Deferasirox API Regions by Sales (2022-2027) 3.5 Global Top Deferasirox API Regions by Revenue 3.5.1 Global Top Deferasirox API Regions by Revenue (2016-2021) 3.5.2 Global Top Deferasirox API Regions by Revenue (2022-2027) 3.6 North America 3.7 Europe 3.8 Asia-Pacific 3.9 Latin America 3.10 Middle East & Africa 4 Competition by Manufactures 4.1 Global Deferasirox API Production Capacity by Manufacturers 4.2 Global Deferasirox API Sales by Manufacturers 4.2.1 Global Top Deferasirox API Manufacturers by Sales (2016-2021) 4.2.2 Global Top Deferasirox API Manufacturers Market Share by Sales (2016-2021) 4.2.3 Global Top 10 and Top 5 Companies by Deferasirox API Sales in 2020 4.3 Global Deferasirox API Revenue by Manufacturers 4.3.1 Global Top Deferasirox API Manufacturers by Revenue (2016-2021) 4.3.2 Global Top Deferasirox API Manufacturers Market Share by Revenue (2016-2021) 4.3.3 Global Top 10 and Top 5 Companies by Deferasirox API Revenue in 2020 4.4 Global Deferasirox API Sales Price by Manufacturers 4.5 Analysis of Competitive Landscape 4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 4.5.2 Global Deferasirox API Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.5.3 Global Deferasirox API Manufacturers Geographical Distribution 4.6 Mergers & Acquisitions, Expansion Plans 5 Market Size by Type 5.1 Global Deferasirox API Sales by Type 5.1.1 Global Deferasirox API Historical Sales by Type (2016-2021) 5.1.2 Global Deferasirox API Forecasted Sales by Type (2022-2027) 5.1.3 Global Deferasirox API Sales Market Share by Type (2016-2027) 5.2 Global Deferasirox API Revenue by Type 5.2.1 Global Deferasirox API Historical Revenue by Type (2016-2021) 5.2.2 Global Deferasirox API Forecasted Revenue by Type (2022-2027) 5.2.3 Global Deferasirox API Revenue Market Share by Type (2016-2027) 5.3 Global Deferasirox API Price by Type 5.3.1 Global Deferasirox API Price by Type (2016-2021) 5.3.2 Global Deferasirox API Price Forecast by Type (2022-2027) 6 Market Size by Application 6.1 Global Deferasirox API Sales by Application 6.1.1 Global Deferasirox API Historical Sales by Application (2016-2021) 6.1.2 Global Deferasirox API Forecasted Sales by Application (2022-2027) 6.1.3 Global Deferasirox API Sales Market Share by Application (2016-2027) 6.2 Global Deferasirox API Revenue by Application 6.2.1 Global Deferasirox API Historical Revenue by Application (2016-2021) 6.2.2 Global Deferasirox API Forecasted Revenue by Application (2022-2027) 6.2.3 Global Deferasirox API Revenue Market Share by Application (2016-2027) 6.3 Global Deferasirox API Price by Application 6.3.1 Global Deferasirox API Price by Application (2016-2021) 6.3.2 Global Deferasirox API Price Forecast by Application (2022-2027) 7 North America 7.1 North America Deferasirox API Market Size by Type 7.1.1 North America Deferasirox API Sales by Type (2016-2027) 7.1.2 North America Deferasirox API Revenue by Type (2016-2027) 7.2 North America Deferasirox API Market Size by Application 7.2.1 North America Deferasirox API Sales by Application (2016-2027) 7.2.2 North America Deferasirox API Revenue by Application (2016-2027) 7.3 North America Deferasirox API Sales by Country 7.3.1 North America Deferasirox API Sales by Country (2016-2027) 7.3.2 North America Deferasirox API Revenue by Country (2016-2027) 7.3.3 United States 7.3.4 Canada 8 Europe 8.1 Europe Deferasirox API Market Size by Type 8.1.1 Europe Deferasirox API Sales by Type (2016-2027) 8.1.2 Europe Deferasirox API Revenue by Type (2016-2027) 8.2 Europe Deferasirox API Market Size by Application 8.2.1 Europe Deferasirox API Sales by Application (2016-2027) 8.2.2 Europe Deferasirox API Revenue by Application (2016-2027) 8.3 Europe Deferasirox API Sales by Country 8.3.1 Europe Deferasirox API Sales by Country (2016-2027) 8.3.2 Europe Deferasirox API Revenue by Country (2016-2027) 8.3.3 Germany 8.3.4 France 8.3.5 U.K. 8.3.6 Italy 8.3.7 Russia 9 Asia Pacific 9.1 Asia Pacific Deferasirox API Market Size by Type 9.1.1 Asia Pacific Deferasirox API Sales by Type (2016-2027) 9.1.2 Asia Pacific Deferasirox API Revenue by Type (2016-2027) 9.2 Asia Pacific Deferasirox API Market Size by Application 9.2.1 Asia Pacific Deferasirox API Sales by Application (2016-2027) 9.2.2 Asia Pacific Deferasirox API Revenue by Application (2016-2027) 9.3 Asia Pacific Deferasirox API Sales by Region 9.3.1 Asia Pacific Deferasirox API Sales by Region (2016-2027) 9.3.2 Asia Pacific Deferasirox API Revenue by Region (2016-2027) 9.3.3 China 9.3.4 Japan 9.3.5 South Korea 9.3.6 India 9.3.7 Australia 9.3.8 China Taiwan 9.3.9 Indonesia 9.3.10 Thailand 9.3.11 Malaysia 10 Latin America 10.1 Latin America Deferasirox API Market Size by Type 10.1.1 Latin America Deferasirox API Sales by Type (2016-2027) 10.1.2 Latin America Deferasirox API Revenue by Type (2016-2027) 10.2 Latin America Deferasirox API Market Size by Application 10.2.1 Latin America Deferasirox API Sales by Application (2016-2027) 10.2.2 Latin America Deferasirox API Revenue by Application (2016-2027) 10.3 Latin America Deferasirox API Sales by Country 10.3.1 Latin America Deferasirox API Sales by Country (2016-2027) 10.3.2 Latin America Deferasirox API Revenue by Country (2016-2027) 10.3.3 Mexico 10.3.4 Brazil 10.3.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Deferasirox API Market Size by Type 11.1.1 Middle East and Africa Deferasirox API Sales by Type (2016-2027) 11.1.2 Middle East and Africa Deferasirox API Revenue by Type (2016-2027) 11.2 Middle East and Africa Deferasirox API Market Size by Application 11.2.1 Middle East and Africa Deferasirox API Sales by Application (2016-2027) 11.2.2 Middle East and Africa Deferasirox API Revenue by Application (2016-2027) 11.3 Middle East and Africa Deferasirox API Sales by Country 11.3.1 Middle East and Africa Deferasirox API Sales by Country (2016-2027) 11.3.2 Middle East and Africa Deferasirox API Revenue by Country (2016-2027) 11.3.3 Turkey 11.3.4 Saudi Arabia 11.3.5 UAE 12 Corporate Profiles 12.1 Piramal Enterprises Limited 12.1.1 Piramal Enterprises Limited Corporation Information 12.1.2 Piramal Enterprises Limited Overview 12.1.3 Piramal Enterprises Limited Deferasirox API Sales, Price, Revenue and Gross Margin (2016-2021) 12.1.4 Piramal Enterprises Limited Deferasirox API Product Description 12.1.5 Piramal Enterprises Limited Recent Developments 12.2 Alkaloids Corporation 12.2.1 Alkaloids Corporation Corporation Information 12.2.2 Alkaloids Corporation Overview 12.2.3 Alkaloids Corporation Deferasirox API Sales, Price, Revenue and Gross Margin (2016-2021) 12.2.4 Alkaloids Corporation Deferasirox API Product Description 12.2.5 Alkaloids Corporation Recent Developments 12.3 Zhejiang Hengkang Pharmaceutical 12.3.1 Zhejiang Hengkang Pharmaceutical Corporation Information 12.3.2 Zhejiang Hengkang Pharmaceutical Overview 12.3.3 Zhejiang Hengkang Pharmaceutical Deferasirox API Sales, Price, Revenue and Gross Margin (2016-2021) 12.3.4 Zhejiang Hengkang Pharmaceutical Deferasirox API Product Description 12.3.5 Zhejiang Hengkang Pharmaceutical Recent Developments 12.4 Om Pharmaceutical Industries 12.4.1 Om Pharmaceutical Industries Corporation Information 12.4.2 Om Pharmaceutical Industries Overview 12.4.3 Om Pharmaceutical Industries Deferasirox API Sales, Price, Revenue and Gross Margin (2016-2021) 12.4.4 Om Pharmaceutical Industries Deferasirox API Product Description 12.4.5 Om Pharmaceutical Industries Recent Developments 12.5 Teva API 12.5.1 Teva API Corporation Information 12.5.2 Teva API Overview 12.5.3 Teva API Deferasirox API Sales, Price, Revenue and Gross Margin (2016-2021) 12.5.4 Teva API Deferasirox API Product Description 12.5.5 Teva API Recent Developments 12.6 Symed Labs Limited 12.6.1 Symed Labs Limited Corporation Information 12.6.2 Symed Labs Limited Overview 12.6.3 Symed Labs Limited Deferasirox API Sales, Price, Revenue and Gross Margin (2016-2021) 12.6.4 Symed Labs Limited Deferasirox API Product Description 12.6.5 Symed Labs Limited Recent Developments 12.7 Neuland Laboratories 12.7.1 Neuland Laboratories Corporation Information 12.7.2 Neuland Laboratories Overview 12.7.3 Neuland Laboratories Deferasirox API Sales, Price, Revenue and Gross Margin (2016-2021) 12.7.4 Neuland Laboratories Deferasirox API Product Description 12.7.5 Neuland Laboratories Recent Developments 12.8 Parabolic Drugs Limited 12.8.1 Parabolic Drugs Limited Corporation Information 12.8.2 Parabolic Drugs Limited Overview 12.8.3 Parabolic Drugs Limited Deferasirox API Sales, Price, Revenue and Gross Margin (2016-2021) 12.8.4 Parabolic Drugs Limited Deferasirox API Product Description 12.8.5 Parabolic Drugs Limited Recent Developments 12.9 YUNG ZIP CHEMICAL INDUSTRIAL 12.9.1 YUNG ZIP CHEMICAL INDUSTRIAL Corporation Information 12.9.2 YUNG ZIP CHEMICAL INDUSTRIAL Overview 12.9.3 YUNG ZIP CHEMICAL INDUSTRIAL Deferasirox API Sales, Price, Revenue and Gross Margin (2016-2021) 12.9.4 YUNG ZIP CHEMICAL INDUSTRIAL Deferasirox API Product Description 12.9.5 YUNG ZIP CHEMICAL INDUSTRIAL Recent Developments 12.10 Erregierre SpA 12.10.1 Erregierre SpA Corporation Information 12.10.2 Erregierre SpA Overview 12.10.3 Erregierre SpA Deferasirox API Sales, Price, Revenue and Gross Margin (2016-2021) 12.10.4 Erregierre SpA Deferasirox API Product Description 12.10.5 Erregierre SpA Recent Developments 12.11 Glenmark Pharmaceuticals 12.11.1 Glenmark Pharmaceuticals Corporation Information 12.11.2 Glenmark Pharmaceuticals Overview 12.11.3 Glenmark Pharmaceuticals Deferasirox API Sales, Price, Revenue and Gross Margin (2016-2021) 12.11.4 Glenmark Pharmaceuticals Deferasirox API Product Description 12.11.5 Glenmark Pharmaceuticals Recent Developments 12.12 Cipla 12.12.1 Cipla Corporation Information 12.12.2 Cipla Overview 12.12.3 Cipla Deferasirox API Sales, Price, Revenue and Gross Margin (2016-2021) 12.12.4 Cipla Deferasirox API Product Description 12.12.5 Cipla Recent Developments 12.13 Sun Pharmaceutical Industries Ltd. 12.13.1 Sun Pharmaceutical Industries Ltd. Corporation Information 12.13.2 Sun Pharmaceutical Industries Ltd. Overview 12.13.3 Sun Pharmaceutical Industries Ltd. Deferasirox API Sales, Price, Revenue and Gross Margin (2016-2021) 12.13.4 Sun Pharmaceutical Industries Ltd. Deferasirox API Product Description 12.13.5 Sun Pharmaceutical Industries Ltd. Recent Developments 12.14 Jubilant Pharma 12.14.1 Jubilant Pharma Corporation Information 12.14.2 Jubilant Pharma Overview 12.14.3 Jubilant Pharma Deferasirox API Sales, Price, Revenue and Gross Margin (2016-2021) 12.14.4 Jubilant Pharma Deferasirox API Product Description 12.14.5 Jubilant Pharma Recent Developments 12.15 CTX Lifesciences 12.15.1 CTX Lifesciences Corporation Information 12.15.2 CTX Lifesciences Overview 12.15.3 CTX Lifesciences Deferasirox API Sales, Price, Revenue and Gross Margin (2016-2021) 12.15.4 CTX Lifesciences Deferasirox API Product Description 12.15.5 CTX Lifesciences Recent Developments 12.16 Waterstone Pharmaceuticals Inc. 12.16.1 Waterstone Pharmaceuticals Inc. Corporation Information 12.16.2 Waterstone Pharmaceuticals Inc. Overview 12.16.3 Waterstone Pharmaceuticals Inc. Deferasirox API Sales, Price, Revenue and Gross Margin (2016-2021) 12.16.4 Waterstone Pharmaceuticals Inc. Deferasirox API Product Description 12.16.5 Waterstone Pharmaceuticals Inc. Recent Developments 12.17 Bal Pharma Ltd. 12.17.1 Bal Pharma Ltd. Corporation Information 12.17.2 Bal Pharma Ltd. Overview 12.17.3 Bal Pharma Ltd. Deferasirox API Sales, Price, Revenue and Gross Margin (2016-2021) 12.17.4 Bal Pharma Ltd. Deferasirox API Product Description 12.17.5 Bal Pharma Ltd. Recent Developments 12.18 Curequest Lifescience 12.18.1 Curequest Lifescience Corporation Information 12.18.2 Curequest Lifescience Overview 12.18.3 Curequest Lifescience Deferasirox API Sales, Price, Revenue and Gross Margin (2016-2021) 12.18.4 Curequest Lifescience Deferasirox API Product Description 12.18.5 Curequest Lifescience Recent Developments 13 Industry Chain and Sales Channels Analysis 13.1 Deferasirox API Industry Chain Analysis 13.2 Deferasirox API Key Raw Materials 13.2.1 Key Raw Materials 13.2.2 Raw Materials Key Suppliers 13.3 Deferasirox API Production Mode & Process 13.4 Deferasirox API Sales and Marketing 13.4.1 Deferasirox API Sales Channels 13.4.2 Deferasirox API Distributors 13.5 Deferasirox API Customers 14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 14.1 Deferasirox API Industry Trends 14.2 Deferasirox API Market Drivers 14.3 Deferasirox API Market Challenges 14.4 Deferasirox API Market Restraints 15 Key Finding in The Global Deferasirox API Study 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables
Table 1. Global Deferasirox API Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Purity≥98%
Table 3. Major Manufacturers of Purity<98%
Table 4. Global Deferasirox API Market Size Growth Rate by Application, 2016 VS 2021 2027 (US$ Million)
Table 5. Global Deferasirox API Production by Region: 2016 VS 2021 VS 2027 (Kiloton)
Table 6. Global Deferasirox API Production by Region (2016-2021) & (Kiloton)
Table 7. Global Deferasirox API Production Market Share by Region (2016-2021)
Table 8. Global Deferasirox API Production by Region (2022-2027) & (Kiloton)
Table 9. Global Deferasirox API Production Market Share by Region (2022-2027)
Table 10. Global Deferasirox API Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 11. Global Deferasirox API Sales by Region (2016-2021) & (Kiloton)
Table 12. Global Deferasirox API Sales Market Share by Region (2016-2021)
Table 13. Global Deferasirox API Sales by Region (2022-2027) & (Kiloton)
Table 14. Global Deferasirox API Sales Market Share by Region (2022-2027)
Table 15. Global Deferasirox API Revenue by Region (2016-2021) & (US$ Million)
Table 16. Global Deferasirox API Revenue Market Share by Region (2016-2021)
Table 17. Global Deferasirox API Revenue by Region (2022-2027) & (US$ Million)
Table 18. Global Deferasirox API Revenue Market Share by Region (2022-2027)
Table 19. Global Deferasirox API Production Capacity by Manufacturers (2016-2021) & (Kiloton)
Table 20. Global Deferasirox API Capacity Market Share by Manufacturers (2016-2021)
Table 21. Global Deferasirox API Production by Manufacturers (2016-2021) & (Kiloton)
Table 22. Global Deferasirox API Production Market Share by Manufacturers (2016-2021)
Table 23. Global Deferasirox API Sales by Manufacturers (2016-2021) & (Kiloton)
Table 24. Global Deferasirox API Sales Share by Manufacturers (2016-2021)
Table 25. Global Deferasirox API Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 26. Global Deferasirox API Revenue Share by Manufacturers (2016-2021)
Table 27. Deferasirox API Price by Manufacturers 2016-2021 (US$/Ton)
Table 28. Global Deferasirox API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 29. Global Deferasirox API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Deferasirox API as of 2020)
Table 30. Deferasirox API Manufacturing Base Distribution and Headquarters
Table 31. Manufacturers Deferasirox API Product Offered
Table 32. Date of Manufacturers Enter into Deferasirox API Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Deferasirox API Sales by Type (2016-2021) & (Kiloton)
Table 35. Global Deferasirox API Sales by Type (2022-2027) & (Kiloton)
Table 36. Global Deferasirox API Sales Share by Type (2016-2021)
Table 37. Global Deferasirox API Sales Share by Type (2022-2027)
Table 38. Global Deferasirox API Revenue by Type (2016-2021) & (US$ Million)
Table 39. Global Deferasirox API Revenue by Type (2022-2027) & (US$ Million)
Table 40. Global Deferasirox API Revenue Share by Type (2016-2021)
Table 41. Global Deferasirox API Revenue Share by Type (2022-2027)
Table 42. Deferasirox API Price by Type (2016-2021) & (US$/Ton)
Table 43. Global Deferasirox API Price Forecast by Type (2022-2027) & (US$/Ton)
Table 44. Global Deferasirox API Sales by Application (2016-2021) & (Kiloton)
Table 45. Global Deferasirox API Sales by Application (2022-2027) & (Kiloton)
Table 46. Global Deferasirox API Sales Share by Application (2016-2021)
Table 47. Global Deferasirox API Sales Share by Application (2022-2027)
Table 48. Global Deferasirox API Revenue by Application (2016-2021) & (US$ Million)
Table 49. Global Deferasirox API Revenue by Application (2022-2027) & (US$ Million)
Table 50. Global Deferasirox API Revenue Share by Application (2016-2021)
Table 51. Global Deferasirox API Revenue Share by Application (2022-2027)
Table 52. Deferasirox API Price by Application (2016-2021) & (US$/Ton)
Table 53. Global Deferasirox API Price Forecast by Application (2022-2027) & (US$/Ton)
Table 54. North America Deferasirox API Sales by Type (2016-2021) & (Kiloton)
Table 55. North America Deferasirox API Sales by Type (2022-2027) & (Kiloton)
Table 56. North America Deferasirox API Revenue by Type (2016-2021) & (US$ Million)
Table 57. North America Deferasirox API Revenue by Type (2022-2027) & (US$ Million)
Table 58. North America Deferasirox API Sales by Application (2016-2021) & (Kiloton)
Table 59. North America Deferasirox API Sales by Application (2022-2027) & (Kiloton)
Table 60. North America Deferasirox API Revenue by Application (2016-2021) & (US$ Million)
Table 61. North America Deferasirox API Revenue by Application (2022-2027) & (US$ Million)
Table 62. North America Deferasirox API Sales by Country (2016-2021) & (Kiloton)
Table 63. North America Deferasirox API Sales by Country (2022-2027) & (Kiloton)
Table 64. North America Deferasirox API Revenue by Country (2016-2021) & (US$ Million)
Table 65. North America Deferasirox API Revenue by Country (2022-2027) & (US$ Million)
Table 66. Europe Deferasirox API Sales by Type (2016-2021) & (Kiloton)
Table 67. Europe Deferasirox API Sales by Type (2022-2027) & (Kiloton)
Table 68. Europe Deferasirox API Revenue by Type (2016-2021) & (US$ Million)
Table 69. Europe Deferasirox API Revenue by Type (2022-2027) & (US$ Million)
Table 70. Europe Deferasirox API Sales by Application (2016-2021) & (Kiloton)
Table 71. Europe Deferasirox API Sales by Application (2022-2027) & (Kiloton)
Table 72. Europe Deferasirox API Revenue by Application (2016-2021) & (US$ Million)
Table 73. Europe Deferasirox API Revenue by Application (2022-2027) & (US$ Million)
Table 74. Europe Deferasirox API Sales by Country (2016-2021) & (Kiloton)
Table 75. Europe Deferasirox API Sales by Country (2022-2027) & (Kiloton)
Table 76. Europe Deferasirox API Revenue by Country (2016-2021) & (US$ Million)
Table 77. Europe Deferasirox API Revenue by Country (2022-2027) & (US$ Million)
Table 78. Asia Pacific Deferasirox API Sales by Type (2016-2021) & (Kiloton)
Table 79. Asia Pacific Deferasirox API Sales by Type (2022-2027) & (Kiloton)
Table 80. Asia Pacific Deferasirox API Revenue by Type (2016-2021) & (US$ Million)
Table 81. Asia Pacific Deferasirox API Revenue by Type (2022-2027) & (US$ Million)
Table 82. Asia Pacific Deferasirox API Sales by Application (2016-2021) & (Kiloton)
Table 83. Asia Pacific Deferasirox API Sales by Application (2022-2027) & (Kiloton)
Table 84. Asia Pacific Deferasirox API Revenue by Application (2016-2021) & (US$ Million)
Table 85. Asia Pacific Deferasirox API Revenue by Application (2022-2027) & (US$ Million)
Table 86. Asia Pacific Deferasirox API Sales by Region (2016-2021) & (Kiloton)
Table 87. Asia Pacific Deferasirox API Sales by Region (2022-2027) & (Kiloton)
Table 88. Asia Pacific Deferasirox API Revenue by Region (2016-2021) & (US$ Million)
Table 89. Asia Pacific Deferasirox API Revenue by Region (2022-2027) & (US$ Million)
Table 90. Latin America Deferasirox API Sales by Type (2016-2021) & (Kiloton)
Table 91. Latin America Deferasirox API Sales by Type (2022-2027) & (Kiloton)
Table 92. Latin America Deferasirox API Revenue by Type (2016-2021) & (US$ Million)
Table 93. Latin America Deferasirox API Revenue by Type (2022-2027) & (US$ Million)
Table 94. Latin America Deferasirox API Sales by Application (2016-2021) & (Kiloton)
Table 95. Latin America Deferasirox API Sales by Application (2022-2027) & (Kiloton)
Table 96. Latin America Deferasirox API Revenue by Application (2016-2021) & (US$ Million)
Table 97. Latin America Deferasirox API Revenue by Application (2022-2027) & (US$ Million)
Table 98. Latin America Deferasirox API Sales by Country (2016-2021) & (Kiloton)
Table 99. Latin America Deferasirox API Sales by Country (2022-2027) & (Kiloton)
Table 100. Latin America Deferasirox API Revenue by Country (2016-2021) & (US$ Million)
Table 101. Latin America Deferasirox API Revenue by Country (2022-2027) & (US$ Million)
Table 102. Middle East and Africa Deferasirox API Sales by Type (2016-2021) & (Kiloton)
Table 103. Middle East and Africa Deferasirox API Sales by Type (2022-2027) & (Kiloton)
Table 104. Middle East and Africa Deferasirox API Revenue by Type (2016-2021) & (US$ Million)
Table 105. Middle East and Africa Deferasirox API Revenue by Type (2022-2027) & (US$ Million)
Table 106. Middle East and Africa Deferasirox API Sales by Application (2016-2021) & (Kiloton)
Table 107. Middle East and Africa Deferasirox API Sales by Application (2022-2027) & (Kiloton)
Table 108. Middle East and Africa Deferasirox API Revenue by Application (2016-2021) & (US$ Million)
Table 109. Middle East and Africa Deferasirox API Revenue by Application (2022-2027) & (US$ Million)
Table 110. Middle East and Africa Deferasirox API Sales by Country (2016-2021) & (Kiloton)
Table 111. Middle East and Africa Deferasirox API Sales by Country (2022-2027) & (Kiloton)
Table 112. Middle East and Africa Deferasirox API Revenue by Country (2016-2021) & (US$ Million)
Table 113. Middle East and Africa Deferasirox API Revenue by Country (2022-2027) & (US$ Million)
Table 114. Piramal Enterprises Limited Corporation Information
Table 115. Piramal Enterprises Limited Description and Major Businesses
Table 116. Piramal Enterprises Limited Deferasirox API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 117. Piramal Enterprises Limited Deferasirox API Product
Table 118. Piramal Enterprises Limited Recent Development
Table 119. Alkaloids Corporation Corporation Information
Table 120. Alkaloids Corporation Description and Major Businesses
Table 121. Alkaloids Corporation Deferasirox API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 122. Alkaloids Corporation Deferasirox API Product
Table 123. Alkaloids Corporation Recent Development
Table 124. Zhejiang Hengkang Pharmaceutical Corporation Information
Table 125. Zhejiang Hengkang Pharmaceutical Description and Major Businesses
Table 126. Zhejiang Hengkang Pharmaceutical Deferasirox API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 127. Zhejiang Hengkang Pharmaceutical Deferasirox API Product
Table 128. Zhejiang Hengkang Pharmaceutical Recent Development
Table 129. Om Pharmaceutical Industries Corporation Information
Table 130. Om Pharmaceutical Industries Description and Major Businesses
Table 131. Om Pharmaceutical Industries Deferasirox API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 132. Om Pharmaceutical Industries Deferasirox API Product
Table 133. Om Pharmaceutical Industries Recent Development
Table 134. Teva API Corporation Information
Table 135. Teva API Description and Major Businesses
Table 136. Teva API Deferasirox API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 137. Teva API Deferasirox API Product
Table 138. Teva API Recent Development
Table 139. Symed Labs Limited Corporation Information
Table 140. Symed Labs Limited Description and Major Businesses
Table 141. Symed Labs Limited Deferasirox API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 142. Symed Labs Limited Deferasirox API Product
Table 143. Symed Labs Limited Recent Development
Table 144. Neuland Laboratories Corporation Information
Table 145. Neuland Laboratories Description and Major Businesses
Table 146. Neuland Laboratories Deferasirox API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 147. Neuland Laboratories Deferasirox API Product
Table 148. Neuland Laboratories Recent Development
Table 149. Parabolic Drugs Limited Corporation Information
Table 150. Parabolic Drugs Limited Description and Major Businesses
Table 151. Parabolic Drugs Limited Deferasirox API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 152. Parabolic Drugs Limited Deferasirox API Product
Table 153. Parabolic Drugs Limited Recent Development
Table 154. YUNG ZIP CHEMICAL INDUSTRIAL Corporation Information
Table 155. YUNG ZIP CHEMICAL INDUSTRIAL Description and Major Businesses
Table 156. YUNG ZIP CHEMICAL INDUSTRIAL Deferasirox API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 157. YUNG ZIP CHEMICAL INDUSTRIAL Deferasirox API Product
Table 158. YUNG ZIP CHEMICAL INDUSTRIAL Recent Development
Table 159. Erregierre SpA Corporation Information
Table 160. Erregierre SpA Description and Major Businesses
Table 161. Erregierre SpA Deferasirox API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 162. Erregierre SpA Deferasirox API Product
Table 163. Erregierre SpA Recent Development
Table 164. Glenmark Pharmaceuticals Corporation Information
Table 165. Glenmark Pharmaceuticals Description and Major Businesses
Table 166. Glenmark Pharmaceuticals Deferasirox API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 167. Glenmark Pharmaceuticals Deferasirox API Product
Table 168. Glenmark Pharmaceuticals Recent Development
Table 169. Cipla Corporation Information
Table 170. Cipla Description and Major Businesses
Table 171. Cipla Deferasirox API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 172. Cipla Deferasirox API Product
Table 173. Cipla Recent Development
Table 174. Sun Pharmaceutical Industries Ltd. Corporation Information
Table 175. Sun Pharmaceutical Industries Ltd. Description and Major Businesses
Table 176. Sun Pharmaceutical Industries Ltd. Deferasirox API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 177. Sun Pharmaceutical Industries Ltd. Deferasirox API Product
Table 178. Sun Pharmaceutical Industries Ltd. Recent Development
Table 179. Jubilant Pharma Corporation Information
Table 180. Jubilant Pharma Description and Major Businesses
Table 181. Jubilant Pharma Deferasirox API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 182. Jubilant Pharma Deferasirox API Product
Table 183. Jubilant Pharma Recent Development
Table 184. CTX Lifesciences Corporation Information
Table 185. CTX Lifesciences Description and Major Businesses
Table 186. CTX Lifesciences Deferasirox API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 187. CTX Lifesciences Deferasirox API Product
Table 188. CTX Lifesciences Recent Development
Table 189. Waterstone Pharmaceuticals Inc. Corporation Information
Table 190. Waterstone Pharmaceuticals Inc. Description and Major Businesses
Table 191. Waterstone Pharmaceuticals Inc. Deferasirox API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 192. Waterstone Pharmaceuticals Inc. Deferasirox API Product
Table 193. Waterstone Pharmaceuticals Inc. Recent Development
Table 194. Bal Pharma Ltd. Corporation Information
Table 195. Bal Pharma Ltd. Description and Major Businesses
Table 196. Bal Pharma Ltd. Deferasirox API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 197. Bal Pharma Ltd. Deferasirox API Product
Table 198. Bal Pharma Ltd. Recent Development
Table 199. Curequest Lifescience Corporation Information
Table 200. Curequest Lifescience Description and Major Businesses
Table 201. Curequest Lifescience Deferasirox API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 202. Curequest Lifescience Deferasirox API Product
Table 203. Curequest Lifescience Recent Development
Table 204. Key Raw Materials Lists
Table 205. Raw Materials Key Suppliers Lists
Table 206. Deferasirox API Distributors List
Table 207. Deferasirox API Customers List
Table 208. Deferasirox API Market Trends
Table 209. Deferasirox API Market Drivers
Table 210. Deferasirox API Market Challenges
Table 211. Deferasirox API Market Restraints
Table 212. Research Programs/Design for This Report
Table 213. Key Data Information from Secondary Sources
Table 214. Key Data Information from Primary Sources
List of Figures
Figure 1. Deferasirox API Product Picture
Figure 2. Global Deferasirox API Market Share by Type in 2020 & 2027
Figure 3. Purity≥98% Product Picture
Figure 4. Purity<98% Product Picture
Figure 5. Global Deferasirox API Market Share by Application in 2020 & 2027
Figure 6. Deferasirox Tablets
Figure 7. Others
Figure 8. Deferasirox API Report Years Considered
Figure 9. Global Deferasirox API Capacity, Production and Utilization (2016-2027) & (Kiloton)
Figure 10. Global Deferasirox API Production Market Share by Region in Percentage: 2020 Versus 2027
Figure 11. Global Deferasirox API Production Market Share by Region (2016-2021)
Figure 12. Global Deferasirox API Production Market Share by Region (2022-2027)
Figure 13. Deferasirox API Production Growth Rate in Europe (2016-2027) & (Kiloton)
Figure 14. Deferasirox API Production Growth Rate in China (2016-2027) & (Kiloton)
Figure 15. Deferasirox API Production Growth Rate in China Taiwan (2016-2027) & (Kiloton)
Figure 16. Deferasirox API Production Growth Rate in India (2016-2027) & (Kiloton)
Figure 17. Global Deferasirox API Sales 2016-2027 (Kiloton)
Figure 18. Global Deferasirox API Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 19. Global Deferasirox API Revenue 2016-2027 (US$ Million)
Figure 20. Global Deferasirox API Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 21. Global Deferasirox API Sales Market Share by Region (2016-2021)
Figure 22. Global Deferasirox API Sales Market Share by Region (2022-2027)
Figure 23. North America Deferasirox API Sales YoY (2016-2027) & (Kiloton)
Figure 24. North America Deferasirox API Revenue YoY (2016-2027) & (US$ Million)
Figure 25. Europe Deferasirox API Sales YoY (2016-2027) & (Kiloton)
Figure 26. Europe Deferasirox API Revenue YoY (2016-2027) & (US$ Million)
Figure 27. Asia-Pacific Deferasirox API Sales YoY (2016-2027) & (Kiloton)
Figure 28. Asia-Pacific Deferasirox API Revenue YoY (2016-2027) & (US$ Million)
Figure 29. Latin America Deferasirox API Sales YoY (2016-2027) & (Kiloton)
Figure 30. Latin America Deferasirox API Revenue YoY (2016-2027) & (US$ Million)
Figure 31. Middle East & Africa Deferasirox API Sales YoY (2016-2027) & (Kiloton)
Figure 32. Middle East & Africa Deferasirox API Revenue YoY (2016-2027) & (US$ Million)
Figure 33. The Top 10 and Top 5 Players Market Share by Deferasirox API Sales in 2020
Figure 34. The Top 10 and Top 5 Players Market Share by Deferasirox API Revenue in 2020
Figure 35. Deferasirox API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 36. Global Deferasirox API Sales Market Share by Type (2016-2027)
Figure 37. Global Deferasirox API Revenue Market Share by Type (2016-2027)
Figure 38. Global Deferasirox API Sales Market Share by Application (2016-2027)
Figure 39. Global Deferasirox API Revenue Market Share by Application (2016-2027)
Figure 40. North America Deferasirox API Sales Market Share by Type (2016-2027)
Figure 41. North America Deferasirox API Revenue Market Share by Type (2016-2027)
Figure 42. North America Deferasirox API Sales Market Share by Application (2016-2027)
Figure 43. North America Deferasirox API Revenue Market Share by Application (2016-2027)
Figure 44. North America Deferasirox API Sales Share by Country (2016-2027)
Figure 45. North America Deferasirox API Revenue Share by Country (2016-2027)
Figure 46. United States Deferasirox API Revenue (2016-2027) & (US$ Million)
Figure 47. Canada Deferasirox API Revenue (2016-2027) & (US$ Million)
Figure 48. Europe Deferasirox API Sales Market Share by Type (2016-2027)
Figure 49. Europe Deferasirox API Revenue Market Share by Type (2016-2027)
Figure 50. Europe Deferasirox API Sales Market Share by Application (2016-2027)
Figure 51. Europe Deferasirox API Revenue Market Share by Application (2016-2027)
Figure 52. Europe Deferasirox API Sales Share by Country (2016-2027)
Figure 53. Europe Deferasirox API Revenue Share by Country (2016-2027)
Figure 54. Germany Deferasirox API Revenue (2016-2027) & (US$ Million)
Figure 55. France Deferasirox API Revenue (2016-2027) & (US$ Million)
Figure 56. U.K. Deferasirox API Revenue (2016-2027) & (US$ Million)
Figure 57. Italy Deferasirox API Revenue (2016-2027) & (US$ Million)
Figure 58. Russia Deferasirox API Revenue (2016-2027) & (US$ Million)
Figure 59. Asia Pacific Deferasirox API Sales Market Share by Type (2016-2027)
Figure 60. Asia Pacific Deferasirox API Revenue Market Share by Type (2016-2027)
Figure 61. Asia Pacific Deferasirox API Sales Market Share by Application (2016-2027)
Figure 62. Asia Pacific Deferasirox API Revenue Market Share by Application (2016-2027)
Figure 63. Asia Pacific Deferasirox API Sales Share by Region (2016-2027)
Figure 64. Asia Pacific Deferasirox API Revenue Share by Region (2016-2027)
Figure 65. China Deferasirox API Revenue (2016-2027) & (US$ Million)
Figure 66. Japan Deferasirox API Revenue (2016-2027) & (US$ Million)
Figure 67. South Korea Deferasirox API Revenue (2016-2027) & (US$ Million)
Figure 68. India Deferasirox API Revenue (2016-2027) & (US$ Million)
Figure 69. Australia Deferasirox API Revenue (2016-2027) & (US$ Million)
Figure 70. China Taiwan Deferasirox API Revenue (2016-2027) & (US$ Million)
Figure 71. Indonesia Deferasirox API Revenue (2016-2027) & (US$ Million)
Figure 72. Thailand Deferasirox API Revenue (2016-2027) & (US$ Million)
Figure 73. Malaysia Deferasirox API Revenue (2016-2027) & (US$ Million)
Figure 74. Latin America Deferasirox API Sales Market Share by Type (2016-2027)
Figure 75. Latin America Deferasirox API Revenue Market Share by Type (2016-2027)
Figure 76. Latin America Deferasirox API Sales Market Share by Application (2016-2027)
Figure 77. Latin America Deferasirox API Revenue Market Share by Application (2016-2027)
Figure 78. Latin America Deferasirox API Sales Share by Country (2016-2027)
Figure 79. Latin America Deferasirox API Revenue Share by Country (2016-2027)
Figure 80. Mexico Deferasirox API Revenue (2016-2027) & (US$ Million)
Figure 81. Brazil Deferasirox API Revenue (2016-2027) & (US$ Million)
Figure 82. Argentina Deferasirox API Revenue (2016-2027) & (US$ Million)
Figure 83. Middle East and Africa Deferasirox API Sales Market Share by Type (2016-2027)
Figure 84. Middle East and Africa Deferasirox API Revenue Market Share by Type (2016-2027)
Figure 85. Middle East and Africa Deferasirox API Sales Market Share by Application (2016-2027)
Figure 86. Middle East and Africa Deferasirox API Revenue Market Share by Application (2016-2027)
Figure 87. Middle East and Africa Deferasirox API Sales Share by Country (2016-2027)
Figure 88. Middle East and Africa Deferasirox API Revenue Share by Country (2016-2027)
Figure 89. Turkey Deferasirox API Revenue (2016-2027) & (US$ Million)
Figure 90. Saudi Arabia Deferasirox API Revenue (2016-2027) & (US$ Million)
Figure 91. UAE Deferasirox API Revenue (2016-2027) & (US$ Million)
Figure 92. Deferasirox API Value Chain
Figure 93. Deferasirox API Production Process
Figure 94. Channels of Distribution
Figure 95. Distributors Profiles
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed

---